Procedures & recovery · patient guide

Hodgkin Lymphoma in China: Reviewing Pathology and Response Scans

If you are considering Hodgkin lymphoma care in China, the two records that most shape a specialist's opinion are the original pathology material and the imaging that shows how the disease has responded to any treatment so far. A Chinese haematology team will want to review those directly, not rely on a summary, before discussing options with you.

Go to the practical guidance ↓
Illustrative image: A doctor discusses with an elderly patient in a consultation room.
Illustrative image; not a photograph of a named hospital or an identified patient.
In this guide

Why the exact lymphoma diagnosis must be confirmed before anything else

Lymphoma is not one disease. Hodgkin lymphoma and the many non-Hodgkin lymphomas differ in how they behave and how they are treated, so the precise diagnosis is the starting point for any useful discussion. A report that says only 'lymphoma' or 'lymphoma, favour Hodgkin' is not enough for a treatment decision.

For an overseas patient, this matters because a Chinese specialist cannot responsibly comment on sequencing, further treatment or a second opinion until the diagnosis is pinned down. If your current report is ambiguous, the first practical step is not to choose a hospital but to ask whether the pathology material itself can be re-reviewed.

This is a records question, not a treatment recommendation. You are not asking a coordinator to diagnose you; you are asking whether the original slides and blocks can be sent so that a pathologist in China can examine them directly.

What a pathology review actually needs from you

A pathology review is a re-examination of the tissue, not a re-reading of a typed summary. The most useful items are the original stained slides, the paraffin blocks if they are available, and the full written report that accompanied them. If immunohistochemistry or other special stains were performed, the reports for those matter too.

Ask your treating centre what it can release and in what form. Some centres lend slides for a limited period; others provide recut sections or digital images. The receiving pathologist will tell you what is acceptable, so the practical move is to ask both sides the same question: what material, in what format, and by what route?

Do not send a complete archive before anyone has asked for it. A short summary first, then the specific material the reviewing pathologist requests, is usually easier to manage and less likely to go astray.

Response scans: what they show and why timing matters

If you have already had treatment, the imaging that shows response is central to any discussion about what comes next. This usually means the scans taken before treatment and the scans taken at the points your treating team chose to assess response. The comparison between them is the point, not any single image.

Send the actual images, not only the radiologist's report. Reports summarise; the reviewing clinician may want to look at specific areas, measure lesions and compare them directly with earlier studies. Ask for the images on disc or through a secure link in the format your current hospital uses.

The timing of response scans is a clinical decision made by your treating team. If you are unsure which scans are relevant, list every scan you have had with its date and body area, and let the reviewing specialist tell you which ones to send.

Earlier treatment: what to document and what not to assume

A clear treatment history changes how a specialist reads your records. Useful details include the names of the drugs used, the number of cycles completed, the dates of each phase, any radiotherapy and its site, and any significant adverse events. If treatment was stopped or changed, note why.

Do not assume that a treatment used elsewhere will be continued, repeated or replaced in China. That is a clinical decision for the treating team after they have reviewed your pathology, imaging and history. Your job at this stage is to make the history legible, not to predict the plan.

If you are currently receiving treatment, do not interrupt it to pursue an overseas enquiry. Ask your current team first, and treat any China-based review as something that runs alongside your existing care rather than replacing it.

How specialist sequencing is decided, and what you can prepare

Sequencing means the order in which assessments and treatments are arranged. For Hodgkin lymphoma, that order depends on the confirmed diagnosis, the stage, the response so far and your overall health. No coordinator can set that order; a haematology team does, after reviewing the records.

The reason sequencing cannot be settled from a summary is that each element changes the next. A diagnosis that turns out to be a different lymphoma type changes which drugs are relevant. A response scan that shows residual activity in one area raises a different question from one that shows resolution everywhere. A treatment history that stopped early for toxicity raises a different question from one completed as planned. None of these can be resolved by a coordinator reading a discharge letter; they require the treating clinician to look at the material and decide what matters.

What you can do is prepare a single, dated timeline: diagnosis, treatment phases, scans and their results, and any complications. Keep it to one page. Reviewers can then ask for the underlying documents they need rather than working through an unstructured file. A one-page timeline also helps you notice gaps in your own records before you send anything.

If you have had treatment at more than one hospital, note which centre holds which document. Pathology slides may sit with the original biopsy hospital, imaging with the treating hospital, and the written report with whichever team requested it. Knowing who holds what saves weeks of back-and-forth once a reviewer asks for a specific item.

It also helps to write down your actual question. 'Is my diagnosis correct?' 'Has the response been adequate?' 'What would you consider next?' A specific question produces a more useful opinion than a general request for advice. If you have several questions, rank them and send the first one or two; a focused review is easier to answer than a broad one.

One more distinction is worth making before you write. A records-based specialist opinion is not the same as hospital acceptance. A clinician can review your pathology and imaging and give a view on the diagnosis and the response; whether a hospital will accept you for treatment is a separate administrative and clinical decision made by that hospital. Treating the two as one step leads to disappointment when a review is positive but admission is not automatic.

Finally, keep the timeline factual. Avoid interpreting your own scans or guessing at staging. State what the reports say and let the reviewer form a view. If a report is unclear to you, say so rather than filling the gap with an assumption; the reviewing clinician can request clarification from the original centre if needed.

Practical next step for an overseas patient

Start with a short summary: your diagnosis as currently stated, the treatment you have had, the scans you hold and the one question you most want answered. An initial enquiry of this kind is free and does not commit you to anything. If a records-based specialist opinion is useful, that can be discussed separately and is optional.

A useful first message is short. State the diagnosis as it currently reads, list the treatment phases with dates, say which scans you hold and in what format, and ask the one question that matters most to you. If you do not yet know whether your slides can be released, say so; that is itself a question the review process can help you frame.

Before you send anything, check two practical points with the hospital you are approaching. First, what it needs in order to review pathology material: original slides, blocks, recut sections or digital images. Second, what it needs for imaging: the images themselves, the reports, or both, and in which format. These answers differ between providers, so ask rather than assume.

If you are mid-treatment, do not pause it for an overseas enquiry. Ask your current team whether a records review can run alongside your existing schedule, and let the reviewing clinician know the dates of your next planned assessment so any opinion is timed usefully.

You can read more about how lymphoma care is approached in China on the lymphoma treatment page, which sets out the general service context. The hospital, not a coordinator, decides whether your case is suitable for review or treatment there.

Keep your current clinical team informed. If your symptoms worsen, seek local medical care rather than waiting on an overseas enquiry.

Related treatment reference

Sources & scope of this guide

References and official service information relevant to this guide.

  1. NCI: Lymphoma Patient Version

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.